Recently reported data demonstrate that Vav3, a Rho Guanine Nucleotide Exchange Factor (Rho GEF) is overexpressed in breast tumors, coexpressed with ER, necessary for proliferation in breast cancer cells, and predictive of response to neoadjuvant endocrine therapies in patients with ER+ tumors. Such data beg the question as to what roles Vav3 plays in modulation of steroid receptor activity in breast cancer and in resistance to current hormonal therapies. Using reporter assays, I provide novel evidence that Vav3 potentiates Estrogen Receptor activity and represses Androgen Receptor activity in breast cancer cells. Vav3 potentiates ligand-dependent estrogen receptor activity in the MCF-7. A truncated, constitutively active form of Vav3, caVav3 potentiates ligand dependent ER activity in both MCF-7 and T47D. Vav3 activates Rho GTPases through its GEF domain. ER potentiation by caVav3 is dependent upon GEF activity. A caVav3 mutant with defective GEF function represses basal and ligand-mediated ER activity in T47D. Although other studies have shown that Vav3 could activate various Rho GTPases, only constitutively active Rac1 mutants potentiated ER activity in both cell lines. Contrastingly, reporter assays were used to show that caVav3 inhibits ligand-mediated AR activity in the AR+ T47D cell line by both R1881 and DHT stimulation. caVav3-mediated repression of AR activity is GEF-dependent, as caVav3 GEF mutants potentiate AR activity. Constitutively active forms of Rho GTPases were found to repress AR activity to different extents, but R1881-mediated AR activity was only significantly repressed by caCdc42. My studies of the effect of androgens on AR protein by western blot show that androgens downregulate AR protein in the highly Vav3 positive T47D cell line. Previous studies have demonstrated that androgens stabilize AR protein in MCF-7, and I now provide evidence that overexpression of Vav3 or caVav3 reverses hormone-mediated AR protein stabilization in MCF-7. These data are especially relevant given recently published data that decreased AR protein levels contributed to failure of response to MPA in patients with metastatic breast cancer. Further breast cancer studies may prove Vav3 to be a potential drug target in hormone dependent, hormone independent, and metastatic disease.

Early Effects of Castration Therapy in Non-malignant and Malignant Prostate Tissue BACKGROUND. Androgen ablation, the standard treatment for advanced prostate cancer, results in increased apoptosis, decreased cell proliferation and subsequent involution of the prostate gland. The mechanisms behind these responses are largely unknown, but effects in the prostatic epithelium are believed to be mediated by primary changes in the stroma. The purpose of this thesis was to investigate short-term cellular effects of castration-induced prostate tissue involution in mice and humans. METHODS. Prostate tissue factors affected by castration were investigated using cDNA-arrays, micro-dissection, RT-PCR, immunohistochemistry and Western blot analysis. The effects of local insulin-like growth factor-1 (IGF-1) administration were investigated in intact and castrated mice. Non-malignant and malignant epithelial and stromal cells were micro-dissected from human prostate biopsies taken before and within two weeks after castration treatment from patients with advanced prostate cancer. These tissue compartments were analyzed by RT-PCR and/or immunohistochemistry for IGF-1, IGF-1 receptor, androgen receptor (AR) and prostate specific antigen (PSA) expression. Treatment-induced changes in these factors were related to apoptosis and proliferation as well as to clinical data and cancer specific survival. RESULTS. Similar to our observations in mouse ventral prostate (VP), non-malignant and malignant human prostate tissues responded with increased epithelial cell apoptosis and decreased proliferation after androgen withdrawal. Also, the PSA mRNA levels were reduced within the first days after therapy both in non-malignant and malignant human prostate epithelial cells. However, neither of these changes was related to subsequent nadir serum PSA or to survival. Locally injected IGF-1 increased epithelial cell proliferation and vascular volume in intact but not in castrated mice. IGF-1 was found to be mostly, but not exclusively, expressed in the stroma, and it decreased rapidly after castration in both humans and mice. This decrease was, however, largely absent in prostate tumor stroma, and tumor stroma cells showed lower pre-treatment levels of AR than stroma surrounding normal epithelial glands. Furthermore, decreased levels of IGF-1 mRNA in the non-malignant and tumor stroma cells, and in tumor epithelial cells in response to castration, were associated with high levels of apoptosis in epithelial cells after therapy. CONCLUSIONS. In the prostate, IGF-1 may be an important mediator of stroma-epithelial cell interaction that is involved in castration-induced epithelial and vascular involution. Moreover, reduced AR in the tumor stroma may play an important role in prostate cancer progression towards androgen-independency, resulting in inadequate IGF-1 reduction and apoptosis induction in response to castration. Most primary tumors initially respond to castration with markedly decreased PSA synthesis and cell proliferation, and moderately increased apoptosis. Death due to metastatic disease is, however, still common, despite primary tumor regression. This may suggest that tumor cells in metastases respond differently to treatment than primary tumor cells, probably influenced by a different and possibly androgen-independent stroma. Further studies should test the hypothesis that the effect of castration therapy can be enhanced by simultaneous blocking of IGF-1 signaling.

Dissertation (Ph.D.)--University of South Florida, 2008. / Includes vita. Includes bibliographical references. Also available online.

Η συμμετοχή της γενετικής, έναντι της περιβαλλοντικής επίδρασης στη συμπεριφορά αποτελεί θεμελιώδες ερώτημα για τις νευροεπιστήμες και αποτελεί πεδίο έντονου ερευνητικού ενδιαφέροντος. Η σεξουαλικότητα είναι μια σύνθετη αλληλεπίδραση πολλαπλών παραγόντων, συμπεριλαμβανομένων ανατομικών, φυσιολογικών, ψυχολογικών, αναπτυξιακών, πολιτιστικών και σχεσιακών παραγόντων. Παρά την υψηλή συχνότητα εμφάνισης της γυναικείας σεξουαλικής δυσλειτουργίας, λιγότερη έμφαση έχει δοθεί στη μελέτη της από την επιστημονική κοινότητα. Το βιολογικό και ψυχολογικό υπόβαθρό της παραμένει ένα υποσχόμενο πεδίο έρευνας καθώς οι διαθέσιμες θεραπείες είναι πολύ λιγότερες συγκριτικά με την ανδρική σεξουαλική δυσλειτουργία. Η σεξουαλική λειτουργία των γυναικών έχει μελετηθεί κατά καιρούς στο σύνδρομο των πολυκυστικών ωοθηκών, λαμβάνοντας υπόψη ερωτηματολόγια σεξουαλικής δραστηριότητας και επίπεδα φυλετικών ορμονών αλλά όχι τους γενετικούς πολυμορφισμούς που μπορεί να εμπλέκονται και να δημιουργούν συγκεκριμένο βιολογικό υπόβαθρο. Η αλληλεπίδραση ορμονών, νευροδιαβιβαστών και περιβαλλοντικών παραγόντων είναι ευρέως αποδεκτή στη διαμόρφωση του υποστρώματος της γυναικείας σεξουαλικότητας αλλά οι τρόποι παραμένουν ακόμα ασαφείς. Για το λόγο αυτό, ο σκοπός της παρούσας μελέτης ήταν η συσχέτιση των πολυμορφισμών του ανδρογονικού υποδοχέα και του υποδοχέα της βαζοπρεσίνης με τη γυναικεία σεξουαλικότητα στις γυναίκες με σύνδρομο πολυκυστικών ωοθηκών. Η επίδραση των ανδρογόνων στη γυναικεία σεξουαλικότητα αποτελεί πεδίο έντονου ερευνητικού ενδιαφέροντος καθώς οι μηχανισμοί αλληλεπίδρασης είναι ιδιαίτερα πολύπλοκοι. Τα ανδρογόνα ασκούν τη δράση τους μέσω πρόσδεσης και ενεργοποίησης των ανδρογονικών υποδοχέων. Το γονίδιο του υποδοχέα των ανδρογόνων αποτελείται από δύο μοτίβα πολυμορφικών επαναλήψεων CAG & GGN που κωδικοποιούν ποικίλου μήκους πολυγλουταμινικών και πολυγλυκινικών περιοχών αντίστοιχα. Έχει επίσης φανεί ότι το αυξημένο μήκος της CAG επαναληπτικής αλληλουχίας πιθανόν να σχετίζεται με μειωμένη δραστικότητα του AR και ως εκ τούτου και με διαταραχές που σχετίζονται με μειωμένη δράση ανδρογόνων Διάφορα νευροπεπτίδια όπως η βαζοπρεσίνη, η αδενοκορτικοτροπίνη, η ωκυτοκίνη κ.α. επιδρούν στην ενήλικο σεξουαλική συμπεριφορά διαφόρων οργανισμών. Η βαζοπρεσίνη και ο υποδοχέας της αποτέλεσαν αντικείμενο μελέτης για την ερμηνεία της ανθρώπινης κοινωνικής και σεξουαλικής συμπεριφοράς. Οι πολυμορφισμοι του AVPR έχουν επίσης σχετιστεί με αλτρουισμό, με μονογαμία και ανάπτυξη σχέσεων δεσμού, γνώση μουσικής και χορού που αντανακλούν αρχέγονες κοινωνικές αλληλεπιδράσεις όπως ιεροτελεστικές κινήσεις και επικοινωνία μέσω ήχων. Το γονίδιο του υποδοχέα της βαζοπρεσίνης διαθέτει τέσσερα μικροδορυφορικά μοτίβα. Ακολουθώντας τις μελέτες στον αρουραίο του αγρού (vole), η προσοχή έχει κυρίως επικεντρωθεί στις μικροδορυφoρικές επαναλήψεις στην περιοχή του υποκινητή. Πρόκειται για τις RS1 {(GATA)14} και RS3 {(CT)4-TT-(CT)8-(GT)24}, που είναι εξαιρετικά πολυμορφικές. Σκοπός της παρούσας εργασίας είναι η διερεύνηση της συσχέτισης της πολυμορφικής CAG περιοχής του ανδρογονικού υποδοχέα και του RS1 πολυμορφισμού του υποδοχέα της βαζοπρεσίνης με την γυναικεία σεξουαλική συμπεριφορά στο σύνδρομο των πολυκυστικών ωοθηκών. Για το λόγο αυτό η παρούσα μελέτη συμπεριέλαβε 40 γυναίκες με σύνδρομο πολυκυστικών ωοθηκών και 94 υγιείς γυναίκες, στις οποίες διενεργήθηκαν ορμονικοί προσδιορισμοί, ψυχομετρικά τεστ για αξιολόγηση της σεξουαλικής λειτουργίας τους και διερεύνηση της συσχέτισης με τα γονοτυπικά τους χαρακτηριστικά (αριθμός επαναλήψεων των πολυμορφικών μοτίβων στα αλληλόμορφά τους). Τα αποτελέσματα της παρούσας εργασίας έδειξαν ότι στην κατηγορία των γυναικών με PCOS η ενεργότητα του υποδοχέα συσχετίστηκε με μειωμένα επίπεδα oιστρογόνων και με αυξημένη ικανοποίηση, γεγονός που υποδηλώνει ότι σε καθεστώς περίσσειας ανδρογονικού ερεθίσματος η γυναικεία σεξουαλικότητα επάγεται. Επίσης στην ίδια ομάδα γυναικών φάνηκε συσχέτιση μεταξύ των υψηλών επιπέδων FSH και των υψηλών αριθμών επαναλήψεων του RS1 πολυμορφισμού, υποδεικνύοντας έναν κεντρικό ρόλο του AVPR στη ρύθμιση της ωοθυλακιορρηξίας των γυναικών με σύνδρομο πολυκυστικών ωοθηκών. / The contribution of genetic versus environmental influence in behavioral analysis is a fundamental question for neuroscience and it is also an area of strong research interest, Sexuality is distinguished by a complex interaction between anatomic, physiologic, psychological, developmental, relational and cultural factors. Despite the high frequency of sexuality disorders in women, scientists have not placed emphasis on this. The biological and psychological background of women’s sexuality disorder still remains a promising field of research, since the available therapies are fewer than those that are used in male sexual dysfunction. Female sexuality has been studied frequently in women with PCOS and has been based on questionnaires of female’s sexual functionality and serum levels of sex steroid hormones. These studies didn’t take account of the genetic polymorphisms which can be involved in a specific biological background. The interaction of hormones, neurotransmitters and environmental factors is widely accepted in the composition of female’s sexual function but the ways that this interaction happens are still unclear. Thus, the aim of our study was to consider the possible association between the genetic polymorphism of androgen receptor gene and vasopressin receptor gene and female sexuality in women with PCOS. The influence of androgens in female sexuality is a field of intense interest in the scientific community, but the ways this interaction occurs are very complicated. Androgens bind and activate androgen receptors.The androgen receptor gene consists of eight exons and encodes a protein with 919 amino acid residues. Exon 1 of the gene consists of two polymorphic repeat (CAG and GGN) motifs, encoding variable lengths of polyglutamine and polyglycine stretches, respectively. Also, it has been proposed that that the increased length of the CAG repeat should associate with decreased AR activity and hence the disorders related to the reduced androgen actions. Many neuropeptides such as vasopressin, oxytocin, adrenocorticotropic hormone (ACTH) etc, affect sexual behavior in many species. Vasopressin and it’s receptor has been well studied in order to interpret human social and sexual behavior. The genetic polymorphisms of the vasopressin receptor gene has been also associated with altruism, monogamy, pair bonding, musical and dancing ability. The latter reflects primitive social interactions such as ritual movements and vocalization. Vasopressin receptor gene is distinguished by three microsatellites in the 5’ flanking region and a fourth in the single intron. Following the vole studies, attention has been primarily focused on two microsatellites in the promoter region, RS1 {{GATA)14} and RS3 {(CT)4-TT-(CT)8-(GT)24}, which are highly polymorphic. The aim of our study is to investigate the association between the polymorphic CAG region of androgen receptor gene and RS1 polymorphism of vasopressin receptor gene with sexual behavior in women with PCOS. Thus, our study included 40 women with PCOS and 94 healthy women. We performed hormonal analysis, psychometric tests to evaluate their sexual functionality and looked into the association with their genetic characteristics (the number of repeats of polymorphic motifs in their alleles). Our results showed that androgen receptor’s activity is associated with low estrogen levels and high sexual satisfaction in women with PCOS. This indicates that in a state of androgen excess, female sexuality is induced. In the same group of women, we noted an association between high levels of FSH and a high number of repeats of RS1 polymorphism. This suggests a central role of vasopressin receptor in the regulation of ovulation in women with PCOS.

This thesis aims to study the effects of endogenous and exogenous hormones and mammographic breast density (BD) on cellular markers in non-cancerous female breast tissue. Women on the waiting list for breast reduction plastic surgery were recruited (n = 79), and randomized to 2 months of hormone therapy or no therapy before surgery. The women had a mammogram and a needle biopsy 2 months before surgery and tissue samples were obtained at the operation. In premenopausal women, estrogen receptor (ER)α levels were associated with age (p = 0.0002), were similar in the follicular and luteal phases of the menstrual cycle and were higher in parous than in nulliparous women (p = 0.009). Current smokers had lower PR levels than non-smokers (p = 0.019). Women on oral contraception had lower ERα (p = 0.048) and PR (p = 0.007) levels than women in the follicular phase. The ERα levels did not differ significantly between postmenopausal estrogen and estrogen-progestogen users, but PR levels were lower among estrogen-progestogen users (p = 0.03). We found lower expression of the genes for decorin and syndecans 1 and 4 in the luteal phase than in the follicular phase, among parous women. Protein levels of the androgen receptor, syndecan-4 and decorin was lower in premenopausal women who were using oral contraceptives (OC) than in those in the follicular phase (p = 0.002 - 0.02), whereas no significant differences between OC use and the luteal phase were found. In premenopausal women, BD was negatively associated with age and body mass index but was similar for the menstrual phases. Breast density was associated with genetic expression of the androgen receptor and remained significant after adjustment for age (rs = 0.56; p = 0.04). After adjustement for age, breast density was also marginally associated with expression of the caspase 3 gene (0.55; 0.053). However, protein levels of caspase 3 was negatively associated (-0.61; 0.03).

Objective To determine the relationship between increased body hair growth in women and serum sex hormone level, body mass index, and clinical signs. Sample and methods The sample group consisted of 186 women, 18–35 year old residents of Lithuania who were referred to the Clinic of Endocrinology, Kaunas University of Medicine Hospital in 2002–2004 and complained for increased body hair growth. Exclusion criteria: 1) taking systemic medications within the period shorter than three months before the beginning of the study; 2) specific reasons of excessive body hair growth, such as androgen secreting adrenal or ovarian tumors, hyperprolactinemia, Cushing syndrome; 3) thyroid dysfunction. A total number of 37 women were excluded from further study. Statistical analysis was performed on 149 women. Increased body hair growth was assessed using Ferriman-Gallwey (F-G) method. Blood samples were drawn in the morning (08:00–10:00 h), in the early follicular phase, with an exclusion of 7 women with amenorrhea, while the blood sample of 12 women with oligomenorrhea was drawn following at least 2 months after the last menstruation. Serum hormones (total testosterone (T), sex hormone binding globulin (SHBG), free androgen index (FAI), dehydroepiandrosterone sulphate (DHEAS) level were measured using the commercial kits. FAI was calculated as follows: T (nmol/l) × 100/ SHBG (nmol/l). Results The significance of correlations between the F-G score and the tested variables decreased in the... [to full text]

We investigated the gestational expression of androgen receptor (AR) and defined its regulation and that of its co-repressors, PSF and p54nrb, by steroid hormones and myometrial stretch in vivo in pregnant and non-pregnant rats. Our data demonstrate that, 1) myometrial AR expression decreases prior to term; 2) AR expression is up-regulated by MPA treatment and down-regulated by mechanical stretch; (3) myometrial PSF protein expression is down-regulated by estrogen signaling and by mechanical stretch, and up-regulated by androgen signaling; (4) while myometrial PSF mRNA expression is also down-regulated by stretch, the regulation by estrogen and P4 on PSF mRNA appear to be opposite to the effects on PSF protein. We conclude that the decreased androgen signaling in late pregnancy (as a result of decreased AR and PSF expression mediated by hormonal and mechanical signals) may contribute to the mechanisms leading to labor initiation.

We investigated the gestational expression of androgen receptor (AR) and defined its regulation and that of its co-repressors, PSF and p54nrb, by steroid hormones and myometrial stretch in vivo in pregnant and non-pregnant rats. Our data demonstrate that, 1) myometrial AR expression decreases prior to term; 2) AR expression is up-regulated by MPA treatment and down-regulated by mechanical stretch; (3) myometrial PSF protein expression is down-regulated by estrogen signaling and by mechanical stretch, and up-regulated by androgen signaling; (4) while myometrial PSF mRNA expression is also down-regulated by stretch, the regulation by estrogen and P4 on PSF mRNA appear to be opposite to the effects on PSF protein. We conclude that the decreased androgen signaling in late pregnancy (as a result of decreased AR and PSF expression mediated by hormonal and mechanical signals) may contribute to the mechanisms leading to labor initiation.

Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro / O objetivo deste estudo foi avaliar o efeito da administração de leptina no lobo ventral da próstata de ratos adultos. Vinte ratos Wistar machos e adultos foram divididos em 2 grupos: L - animais foram injetados com 50 μL diária de leptina (8 μg / 100 g PC, subcutânea) durante quatro dias e C - animais receberam o mesmo volume de solução salina. Perfil lipídico e níveis séricos de testosterona foram avaliados. O lobo ventral da próstata foi processado para análise histomorfométrica. Expressão dos genes da aromatase, receptor de andrógeno, receptores de estrógeno (α e β) e as isoformas dos receptores de leptina longa (Ob-Rb) e curta (Ob-Ra) foram avaliados por PCR em tempo real. Proliferação celular foi avaliada por imuno-histoquímica com PCNA. Os dados foram expressos como média  erro padrão e analisados pelo teste t de Student. Níveis séricos de colesterol aumentaram (C = 39,7 4,2; L = 55,2 4,2, mg / dL, P ≤ 0,02) e de testosterona (C = 1,6 0,43; L = 0,6 0,15, ng / dL, P ≤ 0,03) diminuíram no grupo L. A análise histomorfométrica mostrou uma redução na densidade de células (C = 8868 242; L = 8.211 210, mm2; P ≤ 0,04), na área total (C = 0,24 0,026; L = 0,10 0,009, mm2; P ≤ 0,001) e na área interna dos ácinos (C = 0,16 0,009; L = 0,08 0,006, mm2; P ≤ 0,0002). Por outro lado, houve um aumento na altura do epitélio (C = 17,3 0,3; L = 22,8 0,2 m, P ≤ 0,0001) e no número de ácinos (C = 7,0 0,2; L = 8,7 0,1, mm2; P ≤ 0,0002). As análises histomorfométrica juntamente com os resultados imuno-histoquímicos para PCNA sugerem que a leptina aumenta a proliferação celular. Em relação à expressão gênica, o tratamento de leptina aumentou a expressão de todos os genes, mas ER-α, em mais de 200 vezes em comparação com a expressão no grupo C. Em conclusão, neste trabalho mostramos que a leptina tem um efeito direto sobre a próstata de ratos adultos levando a um aumento na proliferação celular e na expressão gênica da aromatase, receptor de androgênio, nas isoformas dos receptores de leptina e receptores de estrogênios alfa e beta que são importantes para a fisiologia normal do tecido prostático / The aim of this study was to evaluate the effect of leptin administration on the ventral prostate lobe of adult rat. Twenty adult male rats were divided into 2 groups: L - animals were daily injected with 50 μL of leptin (8 g / 100 g BW, subcutaneous) for four days and C -animals received the same volume of saline solution. Lipid profile and testosterone serum levels were evaluated. The prostate ventral lobe was processed for histomorphometric analysis. Gene expression of aromatase, androgen receptor, leptin and estrogen receptors isoforms was evaluated by real-time PCR. Cell proliferation was evaluated by PCNA immunohistochemistry. Data were expressed as mean  standard error and analyzed by students t-test. Serum levels of cholesterol (C = 39.7 4.2; L = 55.2 4.2, mg / dL; P ≤ 0.02) increased and testosterone (C = 1.6 0.43; L = 0.6 0.15, ng / dL; P ≤ 0.03) decreased in L group. The histomorphometric analysis showed a reduction in cell density (C = 8868 242; L = 8211 210, mm2; P ≤ 0.04), in total (C = 0.24 0.026; L = 0.10 0.009, mm2; P ≤ 0.001) and in the internal acini areas (C = 0.16 0.009; L = 0.08 0.006, mm2; P ≤ 0.0002). On the other hand, there was an increase in the epithelial height (C = 17.3 0.3; L = 22.8 0.2, m; P ≤ 0.0001) and in the number of acini (C = 7.0 0.2; L = 8.7 0.1, mm2; P ≤ 0.0002). The histomorphometric analyses together with PCNA immunohistochemistry results suggest that leptin increases cell proliferation. In relation to the gene expression, leptin treatment increased the expression of all genes, but ER-α, in more than 200 times compared to the expression in C group. In conclusion, in this paper we showed that leptin has a direct effect on the prostate gland of adult rats leading to an increase in proliferation and in the gene expression of aromatase, androgen, leptin and estrogen receptors isoforms that are important for the physiology of the prostate gland.

Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro / O objetivo deste estudo foi avaliar o efeito da administração de leptina no lobo ventral da próstata de ratos adultos. Vinte ratos Wistar machos e adultos foram divididos em 2 grupos: L - animais foram injetados com 50 μL diária de leptina (8 μg / 100 g PC, subcutânea) durante quatro dias e C - animais receberam o mesmo volume de solução salina. Perfil lipídico e níveis séricos de testosterona foram avaliados. O lobo ventral da próstata foi processado para análise histomorfométrica. Expressão dos genes da aromatase, receptor de andrógeno, receptores de estrógeno (α e β) e as isoformas dos receptores de leptina longa (Ob-Rb) e curta (Ob-Ra) foram avaliados por PCR em tempo real. Proliferação celular foi avaliada por imuno-histoquímica com PCNA. Os dados foram expressos como média  erro padrão e analisados pelo teste t de Student. Níveis séricos de colesterol aumentaram (C = 39,7 4,2; L = 55,2 4,2, mg / dL, P ≤ 0,02) e de testosterona (C = 1,6 0,43; L = 0,6 0,15, ng / dL, P ≤ 0,03) diminuíram no grupo L. A análise histomorfométrica mostrou uma redução na densidade de células (C = 8868 242; L = 8.211 210, mm2; P ≤ 0,04), na área total (C = 0,24 0,026; L = 0,10 0,009, mm2; P ≤ 0,001) e na área interna dos ácinos (C = 0,16 0,009; L = 0,08 0,006, mm2; P ≤ 0,0002). Por outro lado, houve um aumento na altura do epitélio (C = 17,3 0,3; L = 22,8 0,2 m, P ≤ 0,0001) e no número de ácinos (C = 7,0 0,2; L = 8,7 0,1, mm2; P ≤ 0,0002). As análises histomorfométrica juntamente com os resultados imuno-histoquímicos para PCNA sugerem que a leptina aumenta a proliferação celular. Em relação à expressão gênica, o tratamento de leptina aumentou a expressão de todos os genes, mas ER-α, em mais de 200 vezes em comparação com a expressão no grupo C. Em conclusão, neste trabalho mostramos que a leptina tem um efeito direto sobre a próstata de ratos adultos levando a um aumento na proliferação celular e na expressão gênica da aromatase, receptor de androgênio, nas isoformas dos receptores de leptina e receptores de estrogênios alfa e beta que são importantes para a fisiologia normal do tecido prostático / The aim of this study was to evaluate the effect of leptin administration on the ventral prostate lobe of adult rat. Twenty adult male rats were divided into 2 groups: L - animals were daily injected with 50 μL of leptin (8 g / 100 g BW, subcutaneous) for four days and C -animals received the same volume of saline solution. Lipid profile and testosterone serum levels were evaluated. The prostate ventral lobe was processed for histomorphometric analysis. Gene expression of aromatase, androgen receptor, leptin and estrogen receptors isoforms was evaluated by real-time PCR. Cell proliferation was evaluated by PCNA immunohistochemistry. Data were expressed as mean  standard error and analyzed by students t-test. Serum levels of cholesterol (C = 39.7 4.2; L = 55.2 4.2, mg / dL; P ≤ 0.02) increased and testosterone (C = 1.6 0.43; L = 0.6 0.15, ng / dL; P ≤ 0.03) decreased in L group. The histomorphometric analysis showed a reduction in cell density (C = 8868 242; L = 8211 210, mm2; P ≤ 0.04), in total (C = 0.24 0.026; L = 0.10 0.009, mm2; P ≤ 0.001) and in the internal acini areas (C = 0.16 0.009; L = 0.08 0.006, mm2; P ≤ 0.0002). On the other hand, there was an increase in the epithelial height (C = 17.3 0.3; L = 22.8 0.2, m; P ≤ 0.0001) and in the number of acini (C = 7.0 0.2; L = 8.7 0.1, mm2; P ≤ 0.0002). The histomorphometric analyses together with PCNA immunohistochemistry results suggest that leptin increases cell proliferation. In relation to the gene expression, leptin treatment increased the expression of all genes, but ER-α, in more than 200 times compared to the expression in C group. In conclusion, in this paper we showed that leptin has a direct effect on the prostate gland of adult rats leading to an increase in proliferation and in the gene expression of aromatase, androgen, leptin and estrogen receptors isoforms that are important for the physiology of the prostate gland.